Keratinocyte cancer and its precursors in organ transplant patients

Current Problems in Dermatology (Switzerland)

Volumn 46, Issue , 2015, Pages 49-57

  Jenni, Daniella ^a   Hofbauer, Günther F L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; DICLOFENAC; ETRETIN; FLUOROURACIL; HYALURONIC ACID; IMIQUIMOD; INGENOL MEBUTATE;

ACTINIC KERATOSIS; ARTICLE; BOWEN DISEASE; CHEMOPROPHYLAXIS; DERMATOLOGIST; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; ORGAN TRANSPLANTATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOMA; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KERATOSIS, ACTINIC; SKIN NEOPLASMS; ULTRAVIOLET RADIATION;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; KERATOSIS, ACTINIC; ORGAN TRANSPLANTATION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84929497727     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000366535     Document Type: Article

References (51)

1. Lechler RI, Sykes M, Thomson AW, et al: Organ transplantation - how much of the promise has been realized? Nat Med 2005; 11:605-613.
2. Euvrard S, Kanitakis J, Pouteil-Noble C, et al: Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33:222-229.
3. Webb MC, Compton F, Andrews PA, et al: Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc 1997; 29:828-630.
4. Hiesse C, Rieu P, Kriaa F, et al: Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997; 29:831-833.
5. Lindelöf B, Sigurgeirsson B, Gäbel H, et al: Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513-519.
6. Ramsay HM, Fryer AA, Hawley CM, et al: Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147:950-956.
7. Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-1691.
8. Harwood CA, Mesher D, McGregor JM, et al: A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant 2013; 13:119-129.
9. Jensen P, Hansen S, Møller B, et al: Skin cancer in kidney and heart transplant recipients and different long-term im-munosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177-186.
10. Hartevelt MM, Bavinck JN, Kootte AM, et al: Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49:506-509.
11. Harwood CA, Proby CM, McGregor JM, et al: Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54:290-300.
12. Moloney FJ, Comber H, O'Lorcain P, et al: A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498-504.
13. Ramsay HM, Fryer AA, Hawley CM, et al: Factors associated with nonmelano-ma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397-406.
14. Bouwes Bavinck JN, Euvrard S, Naldi L, et al: Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007; 127:1647-1656.
15. Harwood CA, Surentheran T, McGregor JM, et al: Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocom-petent individuals. J Med Virol 2000; 61: 289-297.
16. Reuschenbach M, Tran T, Faulstich F, et al: High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompe-tent patients. Br J Cancer 2011; 104: 1334-1341.
17. Arron ST, Ruby JG, Dybbro E, et al: Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol 2011; 131: 1745-1753.
18. Servilla KS, Burnham DK, Daynes RA: Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice. Transplantation 1987; 44:291-295.
19. Hojo M, Morimoto T, Maluccio M, et al: Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397:530-534.
20. Otley CC, Hirose R, Salasche SJ: Skin cancer as a contraindication to organ transplantation. Am J Transplant 2005; 5:2079-2084.
21. Jensen AO, Svaerke C, Farkas D, et al: Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010; 90: 474-479.
22. Collett D, Mumford L, Banner NR, et al: Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010; 10:1889-1896.
23. Glover MT, Deeks JJ, Raftery MJ, et al: Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997; 349:398.
24. Sehgal SN: Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 2003; 35:7S-14S.
25. Euvrard S, Morelon E, Rostaing L, et al: Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 2012; 367:329-339.
26. Leblanc Jr KG, Hughes MP, Sheehan DJ: The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2011; 37:744-749.
27. Alberú J, Pascoe MD, Campistol JM, et al: Lower malignancy rates in renal al-lograft recipients converted to sirolim-us-based, calcineurin inhibitor-free im-munotherapy: 24-month results from the CONVERT trial. Transplantation 2011; 92:303-310.
28. Gu YH, Du JX, Ma ML: Sirolimus and non-melanoma skin cancer prevention after kidney transplantation: a meta-analysis. Asian Pac J Cancer Prev 2012; 13:4335-4339.
29. Bouwes Bavinck JNB, Harwood CA, Genders RE, et al: Pain identifies squa-mous cell carcinoma in organ transplant recipients: the SCOPE-ITSCC PAIN Study. Am J Transplant 2014; 14:668-676.
30. Smith KJ, Hamza S, Skelton H: Histolog-ic features in primary cutaneous squa-mous cell carcinomas in immunocom-promised patients focusing on organ transplant patients. Dermatol Surg 2004; 30:634-641.
31. Kempf W, Mertz KD, Hofbauer GFL, et al: Skin cancer in organ transplant recipients. Pathobiology 2013; 80:302-309.
32. Chai H, Brown RE: Field effect in cancer-an update. Ann Clin Lab Sci 2009; 39:331-337.
33. Hu B, Castillo E, Harewood L, et al: Mul-tifocal epithelial tumors and field can-cerization from loss of mesenchymal CSL signaling. Cell 2012; 149:1207-1220.
34. Stasko T, Brown MD, Carucci JA, et al: Guidelines for the management of squa-mous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30:642-650.
35. Ulrich C, Jürgensen JS, Degen A, et al: Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009; 161(Suppl 3):78-84.
36. Butt A, Roberts DL: Renal transplant recipients and protection from sun: need for education. Lancet 1997; 349: 179-180.
37. Cowen EW, Billingsley EM: Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 1999; 40: 697-701.
38. Seukeran DC, Newstead CG, Cunliffe WJ: The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998; 138: 301-303.
39. Hofbauer GF, Anliker M, Arnold A, et al: Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly 2009; 139:407-415.
40. Ulrich C, Johannsen A, Röwert-Huber J, et al: Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses. Eur J Dermatol 2010; 20:482-488.
41. Perrett CM, McGregor JM, Warwick J, et al: Treatment of post-transplant prema-lignant skin disease: a randomized intrapatient comparative study of 5-fluo-rouracil cream and topical photodynamic therapy. Br J Dermatol 2007; 156:320-328.
42. Ulrich C, Bichel J, Euvrard S, et al: Topical immunomodulation under systemic immunosuppression: results of a multi-centre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 2007; 157(Suppl 2):25-31.
43. Lebwohl M, Swanson N, Anderson LL, et al: Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366:1010-1019.
44. Basset-Seguin N, Baumann Conzett K, Gerritsen MJ, et al: Photodynamic therapy for actinic keratosis in organ transplant patients. J Eur Acad Dermatol Ve-nereol 2013; 27:57-66.
45. Wlodek C, Ali FR, Lear JT: Use of photo-dynamic therapy for treatment of actinic keratoses in organ transplant recipients. Biomed Res Int 2012;3:349526.
46. Otley CC, Berg D, Ulrich C, et al: Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006; 154:395-400.
47. George R, Weightman W, Russ GR, et al: Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 2002; 43:269-273.
48. Smit JV, de Sévaux RG, Blokx WA, et al: Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: histologic and immunohistochemi-cal effects. J Am Acad Dermatol 2004; 50:189-196.
49. Harwood CA, Leedham-Green M, Leigh IM, et al: Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol 2005; 141:456-464.
50. Bavinck JN, Tieben LM, Van der Woude FJ, et al: Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995; 13: 1933-1938.
51. Jirakulaporn T, Endrizzi B, Lindgren B, et al: Capecitabine for skin cancer prevention in solid organ transplant recipients. Clin Transplant 2011; 25:541-548.